Inductive Bio
AI Drug Discovery
4 open rolesAI Drug DiscoveryNew York, United States12 employees$29M raisedEst. 2021
Lux Capital
Obvious Ventures
Andreessen Horowitz (a16z) Bio + Health
Section 32
Character
Amino Collective
About Inductive Bio
- Inductive Bio is an AI drug discovery partner developing virtual chemistry labs.
- Their platform uses machine learning to accelerate small molecule development by building datasets and models to map the drivers of absorption, distribution, metabolism, excretion, and toxicity (ADMET) issues, aiming to identify better drug candidates faster.
Inductive Bio is listed on Rocketlist with 4 active roles. The company is categorized as AI Drug Discovery in BioTech. Inductive Bio is at Series A stage, with a B2B business model, headquartered in New York, United States. Inductive Bio was founded in 2021 and has 12 employees. Inductive Bio has raised $29M. Active roles are refreshed daily from public hiring sources.